Risk & reward: Longevity investmentsAuthor: Phil Newman | Published on: April 30, 2020 | Last updated: May 10, 2022 Ronjon NagManaging Director and Founder, R42 GroupRisk & reward: longevity investments Share this article: Editor's choiceLeveraging the past to illuminate longevity for the future‘It’s always too early to say something’s impossible’‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’Calling all longevity clinicians: your voice matters!Combining AI and MRI to improve human longevityAndrew Steele: Curing aging is a question of investment, not time Popular articlesLongevity investment bulletin: NewLimit, ORA, Insilico Medicine and moreStay cool: the longevity tech that “shows insane promise”Does SIRT6 hold the key to human longevity?Tally up! Consumer longevity company lands $10mLongevity: ‘money-spinning cult’ or the future of health?Zuzalu: a pop-up city with longevity at its heart
